Skip to main navigation Skip to search Skip to main content

Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

  • Betty B. Yao
  • , Linda M. Fredrick
  • , Gretja Schnell
  • , Kris V. Kowdley
  • , Paul Y. Kwo
  • , Fred Poordad
  • , Kinh Nguyen
  • , Samuel S. Lee
  • , Christophe George
  • , Florence Wong
  • , Edward Gane
  • , Armand Abergel
  • , Catherine W. Spearman
  • , Tuan Nguyen
  • , Manh Hung Le
  • , Thuy T.T. Pham
  • , Federico Mensa
  • , Tarik Asselah

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science